Cleared Traditional

K090594 - DIMENSION VISTA IMMUNOGLOBULIN A FLEX R...

K090594 is an FDA 510(k) clearance for DIMENSION VISTA IMMUNOGLOBULIN A FLEX R..., manufactured by Siemens Healthcare Diagnostics. The device is a Class 2 Immunology device with product code CFN cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K090594 · Siemens Healthcare Diagnostics · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
55d
Days
Class 2
Risk

K090594 is an FDA 510(k) clearance for the DIMENSION VISTA IMMUNOGLOBULIN A FLEX REAGENT CARTRIDGE (IGA), AND DIMENSION .... Classified as Method, Nephelometric, Immunoglobulins (g, A, M) (product code CFN), Class II - Special Controls.

Submitted by Siemens Healthcare Diagnostics (Newark, US). The FDA issued a Cleared decision on April 29, 2009 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Siemens Healthcare Diagnostics devices

FDA 510(k) Submission Details - K090594

510(k) Number K090594 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2009
Decision Date April 29, 2009
Days to Decision 55 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 104d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFN Device Classification - Class 2, Special Controls

Product Code CFN Method, Nephelometric, Immunoglobulins (g, A, M)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFN Method, Nephelometric, Immunoglobulins (g, A, M)

All 54
Devices cleared under the same product code (CFN) and FDA review panel - the closest regulatory comparables to K090594.
HUMAN IGA2 KIT FOR USE ON THE SPAPLUS
K100588 · The Binding Site Group , Ltd. · Aug 2010
HEVYLITE HUMAN IGA KAPPA AND IGA LAMBDA BN KITS
K082823 · The Binding Site Group , Ltd. · Mar 2010
HUMAN IGG SUBCLASS LIQUID REAGENT KITS (FOR USE ON HITACHI 911/ 912/ 917 AND MODULAR P)
K090920 · The Binding Site, Ltd. · Dec 2009
N ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG, IGA AND IGM) AND N/T PROTEIN CONTROL LC
K083445 · Siemens Healthcare Diagnostics · Mar 2009
HUMAN IGM LIQUID REAGENT KIT FOR USE ON THE SPAPLUS ANALYZER
K082129 · The Binding Site, Ltd. · Feb 2009
HUMAN IGA LIQUID REAGENT KIT FOR USE ON SPAPLUS
K081827 · The Binding Site, Ltd. · Dec 2008